The CTN – CIHR Canadian HIV Trials Network - Research for treatments, prevention and a cure

Other studies (Not affiliated with the CTN)

Non-CTN trials have either not been submitted to, or not been approved by, the CTN. Information on non-CTN trials is the fruit of a partnership between the CTN and CATIE (Canadian AIDS Treament Information Exchange) aiming to provide information about all HIV clinical trials enrolling in Canada.

Other studies that are enrolling participants

> Addition of ezetimibe (Ezetrol®) to ongoing therapy with rosuvastatin (Crestor®) in HIV positive patients not reaching cholesterol targets NEW

Other studies that are ongoing:

> Nutritional intervention for non-alcoholic fatty liver disease

> Kaletra® monotherapy in HIV/HCV co-infection

> Fanconi syndrome due to ARVs in HIV-infected persons

> Lactic acid metabolism

> Vicriviroc in HIV treatment-experienced people

> Ritonavir-boosted elvitegravir versus raltegravir

> Extended release nevirapine QD in treatment-naïve (VERxVE study)

> Fosamprenavir plus Ritonavir or Fosamprenavir alone, in paediatric

> Atazanavir + Ritonavir + Abacavir/Lamivudine Combination in HIV-1 infection (ARIES study)

> Phase II study of TNX-355 with optimized background therapy